Janus Henderson Group’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $872K | Hold |
|
|||||
|
2025
Q2 | $839K | Hold |
|
|||||
|
2025
Q1 | $888K | Hold |
|
|||||
|
2024
Q4 | $1.22M | Buy |
|
|||||
|
2024
Q3 | $1.52M | Hold |
|
|||||
|
2024
Q2 | $1.21M | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $1.09M | Buy |
|
|||||
|
2023
Q2 | $1.55M | Buy |
|
|||||
|
2023
Q1 | $972K | Buy |
|
|||||
|
2022
Q4 | $442K | Sell |
|
|||||
|
2022
Q3 | $976K | Buy |
|
|||||
|
2022
Q2 | $472K | Sell |
|
|||||
|
2022
Q1 | $2.69M | Sell |
|
|||||
|
2021
Q4 | $4.48M | Buy |
|
|||||
|
2021
Q3 | $397K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $440K | Buy |
|